[7] Hosseinzadeh L, Khorand A, Aliabadi A. Discovery of 2‐Phenyl‐N‐(5‐(Trifluoromethyl)‐1, 3, 4‐Thiadiazol‐2‐Yl) Acetamide Derivatives as Apoptosis Inducers via the Caspase Pathway with Potential Anticancer Activity, Arch. Pharm., 346: 812-818 (2013).
[8] Rajak H., Deshmukh R., Aggarwal N., Kashaw S., Kharya M.D., Mishra P.
Synthesis of Novel 2,
5‐Disubstituted 1, 3, 4‐Thiadiazoles for Their Potential Anticonvulsant Activity: Pharmacophoric Model Studies,
Arch. Pharm., 342(8): 453-461 (2009).
[12] Mishra G., Singh A.K., Jyoti K., Review Article on 1, 3, 4-Thiadiazole Derivatives And its Pharmacological Activities, Int. J. Chem. Tech. Res., 3: 1380-1393 (2011).
[13] Singh A.K., Mishra G., Jyoti K., Review on Biological Activities of 1, 3, 4-Thiadiazole Derivatives, J. App. Pharm. Sci., 5: 44-49 (2011).
[15] Kalidhar U., Kaur A., 1, 3, 4-Thiadiazole Derivatives and Their Biological Activities: A Review, Res. J. Pharm. Biol. Chem., 4: 1091-1106 (2011).
[17] Farshori N.N., Banday M.R., Ahmad A., Khan A.U., Rauf A.,
Synthesis, Characterization, and in Vitro Antimicrobial Activities of 5-Alkenyl/Hydroxyalkenyl-2-Phenylamine-1, 3, 4-Oxadiazoles and Thiadiazoles, Bioorg. Med. Chem. Lett., 20(10): 1933-1938 (2010).
[18] Pattan S., Kekare P., Dighe N., Nirmal S., Musmade D., Parjane S., Daithankar A.,
Synthesis and Biological Evaluation of Some 1, 3, 4-Thiadiazoles, J. Chem. Pharm. Res., 1(1): 191-198 (2009).
[21] Almajan G.L, Barbuceanu S-F., Bancescu G., Saramet I., Saramet G., Draghici C.,
Synthesis and Antimicrobial Evaluation of some Fused Heterocyclic [1, 2, 4] Triazolo [3, 4-B][1, 3, 4] Thiadiazole Derivatives,
Eur. J. Med. Chem., 45(12): 6139-6146 (2010).
[22] Noolvi M.N., Patel H.M., Singh N., Gadad A.K., Cameotra S.S., Badiger A.,
Synthesisand Anticancer Evaluation of Novel 2-Cyclopropylimidazo [2, 1-B] [1, 3, 4]-Thiadiazole Derivatives,
Eur. J. Med. Chem., 46(9): 4411-4418 (2011).
[25] Radi M., Crespan E., Botta G., Falchi F., Maga G., Manetti F., Corradi V., Mancini M., Santucci M.A., Schenone S., Botta M.,
Discovery and SAR of 1, 3, 4-Thiadiazole Derivatives as Potent Abl Tyrosine Kinase Inhibitors and Cytodifferentiating Agents,
Bioorg. Med. Chem. Lett., 18(3): 1207-1211 (2008).
[26]Yang X-H., Wen Q., Zhao T-T., Sun J., Li X., Xing M., Lu X., Zhu H.-L.,
Synthesis, Biological Evaluation, And Molecular Docking Studies of Cinnamic Acyl 1, 3, 4-Thiadiazole Amide Derivatives as Novel Antitubulin Agents, Bioorg. Med. Chem., 20(3): 1181-1187 (2012).
[27] Sun J., Yang Y-S., Li W., Zhang Y-B., Wang X-L., Tang J-F., Zhu H.L.,
Synthesis, Biological Evaluation and Molecular Docking Studies of 1, 3, 4-Thiadiazole Derivatives Containing 1, 4-Benzodioxan as Potential Antitumor Agents, Bioorg. Med. Chem. Lett., 21(20): 6116-6121 (2011).
[34] Aliabadi A., Afnanzade N., Hosseinzadeh L., Mohammadi-Farani A., Shafiee M.H., Nazari H., Ahmadi F., Foroumadi A.,
N-(5-(Trifluoromethyl)-1,3,4-Thiadiazol-2-Yl)Benzamide and Benzothioamide Derivatives Induce Apoptosis via Caspase-Dependent Pathway,
Pharm. Chem. J., 53(6): 488-493 (2019).